Search research articles
Contact Us
Filters
Showing results (181-190 of 190) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 190 results.
Nanoscale
|
June 14, 2014
Monolithic NPG nanoparticles with large surface area, tunable plasmonics, and high-density internal hot-spots
Fusheng Zhao, Jianbo Zeng, Md Masud Parvez Arnob, et al.
JACC. Clinical Electrophysiology
|
December 22, 2018
Combination of Left Atrial Appendage Isolation and Ligation to Treat Nonresponders of Pulmonary Vein Isolation
Thomas Fink, Michael Schlüter, Christian-Hendrik Heeger, et al.
World Journal of Urology
|
January 17, 2025
A multicenter study of perioperative and functional outcomes of open vs. robot assisted uretero-enteric reimplantation after radical cystectomy
Tarek Ajami, Mireia Musquera, Joan Palou, et al.
Journal of Endourology
|
February 27, 2025
Outcomes of Minimally Invasive Nephrectomy Following Immune-Checkpoint Inhibitor Therapy: A Multicenter Propensity Score-Matched Analysis
Alireza Ghoreifi, Farshad Sheybaee Moghaddam, Stephan Bronimann, et al.
Heart Rhythm
|
March 18, 2015
Endocardial (Watchman) vs epicardial (Lariat) left atrial appendage exclusion devices: Understanding the differences in the location and type of leaks and their clinical implications
Jayasree Pillarisetti, Yeruva Madhu Reddy, Sampath Gunda, et al.
Cancers
|
July 12, 2025
Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative Group
Maxwell Otiato, Farshad Sheybaee Moghaddam, Alireza Ghoreifi, et al.
Minerva Urology and Nephrology
|
April 23, 2026
Real-world multicenter adherence to international guidelines in the management of upper tract urothelial carcinoma: insights from the ROBUUST 2.0 Registry
Mariaconsiglia Ferriero, Gabriele Tuderti, Flavia Proietti, et al.
World Journal of Urology
|
April 18, 2025
Combined neoadjuvant and adjuvant therapy versus adjuvant therapy in high-risk upper tract urothelial carcinoma: a propensity matched multicenter analysis (ROBUUST 2.0 International Collaborative Group)
Ahmed Eraky, Reuben Ben-David, Gabriele Bignante, et al.
World Journal of Urology
|
September 2, 2025
Radical nephroureterectomy vs kidney sparing surgery for upper tract urothelial carcinoma in solitary kidney patients: a multi-institutional analysis of the ROBUUST 2.0 registry
Francesco Ditonno, Alessandro Veccia, Gabriele Bignante, et al.
Urology Practice
|
June 22, 2026
Metachronous contralateral recurrence in upper tract urothelial carcinoma: a multi-institutional competing-risks analysis from the ROBUUST 3.0 registry
Francesco Ditonno, Alessandro Veccia, Giacomo Musso, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 190) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 190 results.
Nanoscale
|
June 14, 2014
Monolithic NPG nanoparticles with large surface area, tunable plasmonics, and high-density internal hot-spots
Fusheng Zhao, Jianbo Zeng, Md Masud Parvez Arnob, et al.
JACC. Clinical Electrophysiology
|
December 22, 2018
Combination of Left Atrial Appendage Isolation and Ligation to Treat Nonresponders of Pulmonary Vein Isolation
Thomas Fink, Michael Schlüter, Christian-Hendrik Heeger, et al.
World Journal of Urology
|
January 17, 2025
A multicenter study of perioperative and functional outcomes of open vs. robot assisted uretero-enteric reimplantation after radical cystectomy
Tarek Ajami, Mireia Musquera, Joan Palou, et al.
Journal of Endourology
|
February 27, 2025
Outcomes of Minimally Invasive Nephrectomy Following Immune-Checkpoint Inhibitor Therapy: A Multicenter Propensity Score-Matched Analysis
Alireza Ghoreifi, Farshad Sheybaee Moghaddam, Stephan Bronimann, et al.
Heart Rhythm
|
March 18, 2015
Endocardial (Watchman) vs epicardial (Lariat) left atrial appendage exclusion devices: Understanding the differences in the location and type of leaks and their clinical implications
Jayasree Pillarisetti, Yeruva Madhu Reddy, Sampath Gunda, et al.
Cancers
|
July 12, 2025
Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative Group
Maxwell Otiato, Farshad Sheybaee Moghaddam, Alireza Ghoreifi, et al.
Minerva Urology and Nephrology
|
April 23, 2026
Real-world multicenter adherence to international guidelines in the management of upper tract urothelial carcinoma: insights from the ROBUUST 2.0 Registry
Mariaconsiglia Ferriero, Gabriele Tuderti, Flavia Proietti, et al.
World Journal of Urology
|
April 18, 2025
Combined neoadjuvant and adjuvant therapy versus adjuvant therapy in high-risk upper tract urothelial carcinoma: a propensity matched multicenter analysis (ROBUUST 2.0 International Collaborative Group)
Ahmed Eraky, Reuben Ben-David, Gabriele Bignante, et al.
World Journal of Urology
|
September 2, 2025
Radical nephroureterectomy vs kidney sparing surgery for upper tract urothelial carcinoma in solitary kidney patients: a multi-institutional analysis of the ROBUUST 2.0 registry
Francesco Ditonno, Alessandro Veccia, Gabriele Bignante, et al.
Urology Practice
|
June 22, 2026
Metachronous contralateral recurrence in upper tract urothelial carcinoma: a multi-institutional competing-risks analysis from the ROBUUST 3.0 registry
Francesco Ditonno, Alessandro Veccia, Giacomo Musso, et al.
Page
of 19